checkAd

     113  0 Kommentare PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Seite 3

    Information may also be obtained by contacting PharmaCyte’s Investor Relations Department.

    Lesen Sie auch


    The PharmaCyte Biotech Stock at the time of publication of the news with a raise of +0,75 % to 2,70USD on Tradegate stock exchange (19. Dezember 2022, 17:09 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Seite 3 PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box for potential development of cellular therapies for cancer, …